China
# |
Name |
Free Cash Flow Per Share |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 0.97
|
Dec. 31, 2023 | USD 32.04 | NA |
|
China |
|
2 |
USD 0.90
|
Dec. 31, 2023 | USD 10.27 | NA |
|
China |
|
3 |
USD 0.71
|
Dec. 31, 2023 | USD 52.19 | NA |
|
China |
|
4 |
USD 0.68
|
Dec. 31, 2023 | USD 1.74 | NA |
|
China |
|
5 |
USD 0.67
|
Dec. 31, 2023 | USD 2.63 | NA |
|
China |
|
6 |
USD 0.66
|
Dec. 31, 2023 | USD 3.06 | NA |
|
China |
|
7 |
USD 0.66
|
Dec. 31, 2023 | USD 3.55 | NA |
|
China |
|
8 |
USD 0.54
|
Dec. 31, 2023 | USD 3.16 | NA |
|
China |
|
9 |
USD 0.49
|
Dec. 31, 2023 | USD 5.47 | NA |
|
China |
|
10 |
USD 0.49
|
Dec. 31, 2023 | USD 3.80 | NA |
|
China |
|
11 |
USD 0.48
|
Dec. 31, 2023 | USD 4.45 | NA |
|
China |
|
12 |
USD 0.48
|
Dec. 31, 2023 | USD 14.52 | NA |
|
China |
|
13 |
USD 0.46
|
Dec. 31, 2023 | USD 3.32 | NA |
|
China |
|
14 |
USD 0.46
|
Dec. 31, 2023 | USD 4.96 | NA |
|
China |
|
15 |
USD 0.44
|
Dec. 31, 2023 | USD 1.72 | NA |
|
China |
|
16 |
USD 0.44
|
Dec. 31, 2023 | USD 7.07 | NA |
|
China |
|
17 |
USD 0.42
|
Dec. 31, 2023 | USD 8.37 | NA |
|
China |
|
18 |
USD 0.39
|
Dec. 31, 2023 | USD 2.18 | NA |
|
China |
|
19 |
USD 0.37
|
Dec. 31, 2023 | USD 7.19 | NA |
|
China |
|
20 |
USD 0.37
|
Dec. 31, 2023 | USD 3.40 | NA |
|
China |
|
21 |
USD 0.37
|
Dec. 31, 2023 | USD 6.10 | NA |
|
China |
|
22 |
USD 0.35
|
Dec. 31, 2023 | USD 3.88 | NA |
|
China |
|
23 |
USD 0.28
|
Dec. 31, 2023 | USD 1.14 | NA |
|
China |
|
24 |
USD 0.28
|
Dec. 31, 2023 | USD 4.94 | NA |
|
China |
|
25 |
USD 0.28
|
Dec. 31, 2023 | USD 1.44 | NA |
|
China |
|
26 |
USD 0.27
|
Dec. 31, 2023 | USD 0.63 | NA |
|
China |
|
27 |
USD 0.27
|
Dec. 31, 2023 | USD 7.68 | NA |
|
China |
|
28 |
USD 0.23
|
Dec. 31, 2023 | USD 7.99 | NA |
|
China |
|
29 |
USD 0.22
|
Dec. 31, 2023 | USD 9.61 | NA |
|
China |
|
30 |
USD 0.21
|
Dec. 31, 2023 | USD 2.25 | NA |
|
China |
|
31 |
USD 0.20
|
Dec. 31, 2023 | USD 2.99 | NA |
|
China |
|
32 |
USD 0.20
|
Dec. 31, 2023 | USD 8.53 | NA |
|
China |
|
33 |
USD 0.19
|
Dec. 31, 2023 | USD 2.35 | NA |
|
China |
|
34 |
USD 0.19
|
Dec. 31, 2023 | USD 0.67 | NA |
|
China |
|
35 |
USD 0.19
|
Dec. 31, 2023 | USD 9.42 | NA |
|
China |
|
36 |
USD 0.19
|
Dec. 31, 2023 | USD 5.83 | NA |
|
China |
|
37 |
USD 0.19
|
Dec. 31, 2023 | USD 4.80 | NA |
|
China |
|
38 |
USD 0.18
|
Dec. 31, 2023 | USD 1.82 | NA |
|
China |
|
39 |
USD 0.18
|
Dec. 31, 2023 | USD 2.46 | NA |
|
China |
|
40 |
USD 0.18
|
Dec. 31, 2023 | USD 2.50 | NA |
|
China |
|
41 |
USD 0.17
|
Dec. 31, 2023 | USD 1.95 | NA |
|
China |
|
42 |
USD 0.17
|
Dec. 31, 2023 | USD 2.66 | NA |
|
China |
|
43 |
USD 0.16
|
Dec. 31, 2023 | USD 2.42 | NA |
|
China |
|
44 |
USD 0.16
|
Dec. 31, 2023 | USD 1.46 | -0.02% |
|
China |
|
45 |
USD 0.16
|
Dec. 31, 2023 | USD 5.10 | NA |
|
China |
|
46 |
USD 0.16
|
Dec. 31, 2023 | USD 3.37 | NA |
|
China |
|
47 |
USD 0.15
|
Dec. 31, 2023 | USD 3.27 | NA |
|
China |
|
48 |
USD 0.15
|
Dec. 31, 2023 | USD 4.00 | NA |
|
China |
|
49 |
USD 0.15
|
Dec. 31, 2023 | USD 1.18 | NA |
|
China |
|
50 |
USD 0.15
|
Dec. 31, 2023 | USD 1.62 | NA |
|
China |
The Healthcare company in China with the highest Free Cash Flow Per Share is Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (Shenzhen Stock Exchange: 300760.SZ) at USD 0.97.
The Healthcare company in China with the lowest Free Cash Flow Per Share is Burning Rock Biotech Limited (NasdaqGM: BNR) at USD -3.65.
The top 10 Healthcare companies in China by Free Cash Flow Per Share are Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Asymchem Laboratories (Tianjin) Co., Ltd., APT Medical Inc., Cachet Pharmaceutical Co., Ltd., Sinopharm Group Co. Ltd., Yunnan Jianzhijia Health-Chain Co., Ltd., China National Accord Medicines Corporation Ltd., Yifeng Pharmacy Chain Co., Ltd., Andon Health Co., Ltd. and Hubei Jumpcan Pharmaceutical Co., Ltd..
The bottom 10 Healthcare companies in China by Free Cash Flow Per Share are Burning Rock Biotech Limited, China Jo-Jo Drugstores, Inc., I-Mab, Zai Lab Limited, Hangzhou Alltest Biotech Co., Ltd., Connect Biopharma Holdings Limited, CanSino Biologics Inc., Beijing Hotgen Biotech Co., Ltd., Adagene Inc. and RemeGen Co., Ltd..